TNFSF11 Antibody Blocking peptide

Tumor necrosis factor ligand superfamily member 11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, Receptor activator of nuclear factor kappa-B ligand, RANKL, TNF-related activation-induced cytokine, TRANCE, CD254, Tumor necrosis factor ligand superfamily member 11, membrane form, Tumor necrosis factor ligand superfamily member 11, soluble form, TNFSF11, OPGL, RANKL, TRANCE

The synthetic peptide sequence used to generate the antibody orb1928220 was selected from the N-term region of human TNFSF11. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.